documents: FDA-2011-N-0830-0023
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-N-0830-0023 | FDA | FDA-2011-N-0830 | Reference 1 - Federal Trade Commission, Report on “Generic Drug Entry Prior to Patent Expiration An FTC Study” (July 2002) re Abbreviated New Drug Applications and 505(b)(2) Applications | Supporting & Related Material | Background Material | 2016-10-06T04:00:00Z | 2016 | 10 | 2016-10-06T15:45:47Z | 0 | 0 | 09000064822a0aab |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref